Company intelligence / Profile preview

Apical

Ownership: Private
Development stage: Commercial

Overview

Apical has established itself as a reputable CDMO specializing in cold ethanol extraction, vacuum-assisted separations, emulsions, and GMP-compliant manufacturing processes for hemp-derived cannabinoids. The company supports clients through design to implementation phases with an emphasis on quality control and regulatory compliance. No direct clinical trial results are reported since it does not develop its own therapeutics but enables others' commercialization efforts[5][9].

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

BASFBoehringer IngelheimThermoFisher ScientificMammoth Farms

Beyond the preview

Go deeper on Apical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apical.

Explore the full profile